Results 1 to 10 of about 369,175 (312)
Recruitment strategies to increase racial and ethnic diversity in anorexia nervosa clinical research
Objective Inclusion of underrepresented racial and ethnic groups in eating disorder (ED) research is a critical unmet need, but evidence-based recruitment strategies are lacking.
Julianne Strauch +4 more
doaj +1 more source
Malignant insulinomas are functional neuroendocrine tumors of the pancreas and the primary cause of tumor-related hypoglycemia. Malignant insulinoma is rare and has a poor prognosis.
Sandrine Oziel-Taieb +5 more
doaj +1 more source
Background It has been manifested in several studies that age-related metabolic reprogramming is associated with tumor progression, in particular, colorectal cancer (CRC).
Chunhua Hu +9 more
doaj +1 more source
Background N6-methyladenosine (m6A) modification is the most abundant reversible methylation modification in eukaryotes, and it is reportedly closely associated with a variety of cancers progression, including colorectal cancer (CRC).
Mujie Ye +10 more
doaj +1 more source
Background Avoidant/restrictive food intake disorder (ARFID) is a restrictive eating disorder commonly associated with medical complications of undernutrition and low weight.
Aluma Chovel Sella +11 more
doaj +1 more source
The process of post-transcriptional regulation has been recognized to be significantly impacted by the presence of N6-methyladenosine (m6A) modification.
Jinhao Chen +12 more
doaj +1 more source
Anorexia nervosa (AN) and atypical AN (AtypAN) are complex neurobiological illnesses that typically onset in adolescence with an often treatment-refractory and chronic illness trajectory.
Kamryn T. Eddy +15 more
doaj +1 more source
26RFa is a neuropeptide that activates the rhodopsin-like G protein-coupled receptor QRFPR/GPR103. This peptidergic system is involved in the regulation of a wide array of physiological processes including feeding behavior and glucose homeostasis. Herein,
Benjamin Lefranc +12 more
doaj +1 more source
Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors
Background: Plasma chromogranin A (CgA) is related to tumor burden and recommended in the follow-up of patients diagnosed with neuroendocrine tumors (NETs). The use of CgA in the workup of a suspected NET is more questionable.
Jonas Baekdal +11 more
doaj +1 more source
Increasing evidence indicates that long non-coding RNA (lncRNA) is one of the most important RNA regulators in the pathogenesis of neuroblastoma (NB). Here, we found that FAM201A was low expressed in NB and a variety of gain and loss of function studies ...
Mujie Ye +11 more
doaj +1 more source

